|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Pellagra secondary to 5-fluorouracil显示文摘 | Stevens HP Ostlere LS Begent RH | | 0，，05： | 1 |
| 2 | Results with EMA/CO (etoposide,methotrexate,actinomycin D,cyclophosphamide and vincristine) regimen in high-risk gestational trophoblastic tumours,1979 to 1989显示文摘 | Bagshawe KD Begent RH | 1991 | Br J Obstet Gynecol1991，98，6： | 1 |
| 3 | Results with EMA/ CO (etoposide, methotrexate, actinomycin D, cyclophosphanfide, vincristine) regimen in high-risk gestational trophoblastic tumors 1979 - 1989显示文摘 | Newlands ES Bagshawe KD Begent RH | 1991 | Br J Obstet Gynecol1991，98，6： | 1 |
| 4 | Results with the EMA/CO (etoposide, methotrexate, actinomycin D, eyelophosphamide, vineristine ) regimen in high risk gestational trophoblastic tumours, 1979 to 1989显示文摘 | Newlands ES Bagshawe KD Begent RH | 1991 | Br J Obstet Gynaecol1991，98，6： | 1 |
| 5 | In situ and slot hybridization analysis of RNA in colorectal tumors and normal colon shows distinct distributions of mitochondrial sequences 显示文摘 | Robson L Begent RH | 1990 | J Pathol1990，162，： | 1 |
| 6 | Results with the EMA/CO ( etoposide, methotrexate, actinomycin D,cyclophosphamide, vincristine) regimen in high risk gestational trophublastic turnouts, 1979-1989 显示文摘 | Newlands ES Bagshawe KD Begent RH | 1991 | Br J Obstet Gynaecol1991，98，： | 1 |
| 7 | Preliminary Doppler studies on the uterine artery and myometrium in trophoblastic tu- mours reguiring chemotherapy 显示文摘 | Long M G Boultbee JE Begent RH | 1990 | Br J Obstet GynaecoL1990，97，8： | 1 |
| 8 | Resultswith EMA / CO (etoposide, methotrexate,actinomycin D,cyclophosphamide and vincristine) regimen in highriskgestational trophoblastic tumours, 1979 to 1989显示文摘 | Newlands ES Bagshawe KD Begent RH | 1991 | Br JObstet Gynecol1991，98，6： | 1 |
| 9 | Clinical evidence ofeffi cient tumor targeting based on single-chain Fv antibody selectedfrom a combinatorial library显示文摘 | Begent RH Verhaar MJ Chester KA | 1996 | Nat Med1996，2，9： | 1 |
| 10 | Results with EMA/CO(etoposide,methotrexate,actinomycin D,cyclophosphamide and vincristine) regimen in highrisk gestational trophoblastic turnouts,1979 to 1989显示文摘 | Newlands ES Bagshawe KD Begent RH | 1991 | Br J Obstet Gynecol1991，98，6： | 1 |
| 11 | The management of high-risk choriocarcinoma 显示文摘 | Begent RH Bagshawe KD | 1982 | Semin Oncol1982，9，2： | 1 |
| 12 | Results with the EMA/CO ( etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989 显示文摘 | Newlands ES Bagshawe KD Begent RH | 1991 | Br J Obstet Gynaecol1991，98，6： | 1 |
| 13 | Pellagra secondary to 5-fluorouracil显示文摘 | Ostlere LS Begent RH | 1993 | Br J Dermatol1993，128，5： | 1 |
| 14 | Weekly alternating etoposide, methotrexate and actinomycin/vincristine and cyclophosphamide chemotherapy for the treatment of CNS metastases of choriocarcinoma 显示文摘 | Rustin GJ Newlands ES Begent RH | 1989 | Journal of Clinical Oneology1989，7，7： | 1 |
| 15 | Results with the EMA/ CO ( etoposide, methotrexate, actinomycin D, cyclophosphamide, vincris- tine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989显示文摘 | Newlands ES Bagshawe KD Begent RH | 1991 | Br J Obstet Gynaecol1991，98，6： | 1 |
| 16 | Antibody-directed enzyme prodrug therapy(ADEPT)for cancer显示文摘 | Bagshawe KD Sharma SK Begent RH | 2004 | Expert opin Biol Ther2004，4，11： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员